XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.22.4

Fair Value Measurements of Financial Instruments | 12 Months Ended
--- | ---
Dec. 31, 2022
Fair Value Disclosures [Abstract] |
Fair Value Measurements of Financial Instruments | Fair Value Measurements of Financial Instruments For recognition purposes, on a recurring basis, the Corporation is required to measure at fair value its marketable securities, derivative financial instruments, put option liabilities, and deferred stock-based compensation. The marketable securities are comprised of money market funds, government securities, and corporate bonds. When available, the Corporation uses quoted market prices to determine fair value and classifies such measurements within Level 1. Where market prices are not available, the Corporation makes use of observable market-based inputs (prices or quotes from published exchanges and indexes) to calculate fair value using the market approach, in which case the measurements are classified within Level 2. Significant unobservable inputs, which are classified within Level 3, are used in the estimation of the fair value of put option liabilities, determined using a simulation model based on assumptions including future cash flows, discount rates, and volatility. Financial instruments measured at fair value were as follows:
| Fair value as of measurement date |  | Quoted prices in active markets for identical assets (Level 1) |  | Significant other observable inputs (Level 2) |  | Significant unobservable inputs (Level 3)
Balance as of December 31, 2022 |  |  |  |  |  |  |
Cash and cash equivalents (including money market funds) (1) | $ | 17.4 |  |  | $ | 17.4 |  |  | $ | — |  |  | $ | — |
Government securities (2) | $ | 5.6 |  |  | $ | — |  |  | $ | 5.6 |  |  | $ | — |
Corporate bonds (2) | $ | 7.2 |  |  | $ | — |  |  | $ | 7.2 |  |  | $ | — |
Deferred stock-based compensation (4) | $ | (4.7) |  |  | $ | — |  |  | $ | (4.7) |  |  | $ | — |
Put option liability (5) | $ | (5.1) |  |  | $ | — |  |  | $ | — |  |  | $ | (5.1) |
Balance as of January 1, 2022 |  |  |  |  |  |  |
Cash and cash equivalents (including money market funds) (1) | $ | 52.3 |  |  | $ | 52.3 |  |  | $ | — |  |  | $ | — |
Government securities (2) | $ | 5.5 |  |  | $ | — |  |  | $ | 5.5 |  |  | $ | — |
Corporate bonds (2) | $ | 7.8 |  |  | $ | — |  |  | $ | 7.8 |  |  | $ | — |
Derivative financial instruments - liability (3) | $ | (1.0) |  |  | $ | — |  |  | $ | (1.0) |  |  | $ | — |
Deferred stock-based compensation (4) | $ | (8.1) |  |  | $ | — |  |  | $ | (8.1) |  |  | $ | — |
Put option liability (5) | $ | (5.1) |  |  | $ | — |  |  | $ | — |  |  | $ | (5.1) |
Amounts in parentheses indicate liabilities. The index below indicates the line item in the Consolidated Balance Sheets where the financial instruments are reported: (1) "Cash and cash equivalents" (2) Current portion - "Short-term investments"; Long-term portion - "Other Assets" (3) Current portion - "Accounts payable and accrued expenses"; Long-term portion - "Other Long-Term Liabilities" (4) Current portion - "Current maturities of other long-term obligations"; Long-term portion - "Other Long-Term Liabilities" (5) "Other Long-Term Liabilities"

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration